Annual Symposium on Nonhuman Primates

非人类灵长类动物年度研讨会

• 批准号: 10676977
• 负责人: R. PAUL JOHNSON
• 金额: $ 7.5万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10676977
• 关键词: AIDS Vaccines; Acceleration; Acquired Immunodeficiency Syndrome; Address; Adult; Antibodies; Applications Grants; Budgets; COVID-19 pandemic; COVID-19 pathogenesis; COVID-19 treatment; COVID-19 vaccine; California; Child; Clinic; Clinical; Collaborations; Communicable Diseases; Development; Disease; Emerging Technologies; Fees; Fostering; Funding; Future; Generations; Genomics; Grant; HIV; HIV Infections; HIV Vaccine Trials Network; HIV vaccine; HIV/AIDS; Health; Human; Hybrids; Immunologic Deficiency Syndromes; Immunology; Individual; International; Intervention; Journals; Knowledge; Life; Link; Logistics; Medical; Mentors; Mission; Modeling; NIH Vaccine Research Center; Oral; Oregon; Participant; Pathogenesis; Pennsylvania; Persons; Prevention; Preventive vaccine; Primates; Publishing; Research; Research Personnel; Role; Rotation; SIV; Scientific Advances and Accomplishments; Scientist; Technology; Testing; Translations; United States National Institutes of Health; Vaccines; Virus Diseases; Writing; antiretroviral therapy; co-infection; coronavirus disease; cost; disability; experience; falls; global health; meetings; neutralizing antibody; nonhuman primate; novel therapeutics; originality; posters; prevent; programs; response; symposium; therapy design; transmission process

PROJECT SUMMARY With this R13 application, we request funding to support, in part, the costs for planning, publicizing, and hosting the 39th, 40th, and 41st Annual Symposia on Nonhuman Primate Models for AIDS. For four decades, this symposium has served as the premier scientific forum for the exchange of information, including new research findings and scientific perspectives, among HIV/AIDS investigators whose research includes studies in nonhuman primates (NHPs). Disseminating the latest research findings in NHP models of AIDS while also facilitating discussion and exchange of information between basic scientists and clinicians remains a priority, as do focusing on emerging technologies to accelerate translation of NHP studies into the clinic and engaging a broader and more diverse group of researchers in HIV/AIDS research in NHP models. This meeting, the only one of its kind in the world, convenes an international group of scientists whose research focuses on the study of natural and experimental immunodeficiency virus infections in NHPs, as well as on the development of novel therapeutics, prophylactic vaccines for HIV, and curative approaches. Emerging topics in related infectious diseases (such as COVID-19 pathogenesis, vaccines and treatment) may also be included. The seven National Primate Research Centers (NPRCs) host this meeting in rotation, and upcoming symposia hosts will be the Yerkes (2022), California (2023), and Tulane (2024) NPRCs. We plan a hybrid format with most participants attending in person and others joining online to access oral and poster sessions. The conference will begin on day 1 with registration, a keynote address by a leading HIV/AIDS researcher, and an evening reception. The following two and a half days will include scientific presentations from invited speakers and accepted oral abstracts. Each symposium scientific committee will select session topics and speakers to highlight new and cutting-edge technologies in their respective fields. Each session will open with a 30-minute talk by an invited chair. Individuals whose abstracts are accepted for oral presentations will give the remaining session talks. A poster session will occur on the evening of day 2, and there will be a banquet on the evening of day 3. As is traditional for this symposium, the Journal of Medical Primatology will publish all poster and oral abstracts in a special issue. In partnership with the HIV Vaccine Trials Network (HVTN), the NHP AIDS Symposium will also host a pre-symposium meeting for early stage investigators (ESI). This meeting will be open to the attendees of a linked ESI Conference the HVTN sponsors. ESI attendees and mentors will focus on grant writing, budgeting, and networking, and will participate in a Q&A with NIH Program Officers. We believe bringing together researchers from a variety of diverse backgrounds will generate future collaborations and scientific advances. Knowledge shared and gained at upcoming Annual Nonhuman Primate Models for AIDS Symposia will further the continued, effective use of NHP models to maintain long term control of HIV replication in the absence of antiretroviral therapy and to design interventions to prevent or eradicate HIV infection.

项目摘要 通过这个R13应用程序，我们请求资金支持，部分用于规划，宣传和托管的成本 第39届、第40届和第41届非人类灵长类动物艾滋病模型年会。四十年来，这 研讨会已成为交流信息，包括新研究的首要科学论坛 艾滋病毒/艾滋病调查人员的研究包括以下方面的研究： 非人灵长类动物（NHP）。传播艾滋病NHP模型的最新研究成果，同时 促进基础科学家和临床医生之间的讨论和信息交流仍然是一个优先事项， 关注新兴技术，加速NHP研究转化为临床， 一个更广泛和更多样化的研究人员群体在艾滋病毒/艾滋病研究的NHP模型。这次会议，唯一 它是世界上同类组织之一，召集了一个国际科学家小组，其研究重点是研究 自然和实验性免疫缺陷病毒感染的NHP，以及对发展新的 治疗剂、HIV的预防性疫苗和治疗方法。传染病相关领域的新课题 疾病（如COVID-19发病机制、疫苗和治疗）也可包括在内。国家七 灵长类动物研究中心（NPRCs）轮流主办这次会议，即将举行的研讨会主办单位将是 Yerkes（2022）、加州（2023）和杜兰（2024）NPRC。我们计划采用混合形式， 亲自参加，其他人在线参加口头和海报会议。会议将于开始 第一天登记，一位主要的艾滋病毒/艾滋病研究人员发表主旨演讲，并举行晚宴。的 接下来的两天半将包括受邀演讲者的科学演讲和接受的口头演讲。 摘要。每次研讨会科学委员会将选择会议主题和发言人，以突出新的和 各自领域的尖端技术。每个会议将由一位受邀的演讲者进行30分钟的演讲。 椅子个人的摘要被接受为口头报告将给其余的会议发言。一 第二天晚上将举行海报会，第三天晚上将举行宴会。如 作为这次研讨会的传统，《医学灵长类动物学杂志》将以一种 特刊与艾滋病毒疫苗试验网络（HVTN）合作，NHP艾滋病专题讨论会还将 为早期研究人员举办研讨会前会议（ESI）。本次会议将向与会者开放 HVTN赞助的一个相关的ESI会议。ESI与会者和导师将专注于赠款写作， 预算和网络，并将参加与NIH项目官员的问答。我们相信 来自各种不同背景的研究人员将在未来开展合作， 预付款。在即将举行的年度艾滋病非人类灵长类动物模型研讨会上分享和获得的知识 将进一步持续有效地使用NHP模型，以维持对艾滋病毒复制的长期控制， 因此，我们需要采取措施，以消除缺乏抗逆转录病毒疗法的现象，并设计干预措施，预防或根除艾滋病毒感染。